Effect of cholestyramine on the symptoms of reflux gastritis. A randomized, double blind, crossover study.
Bile acids have been proposed to be important in the pathophysiology of the syndrome of "bile reflux gastritis" after surgery. To examine the role of cholestyramine, an ion exchange resin that binds bile acids, on symptoms of this syndrome, we did a randomized, double-blind crossover study on 16 patients. No differences in frequency of abdominal pain, nausea, vomiting, or bitter taste were observed among cholestyramine (4 g, three times daily for 3 weeks), placebo, and routine (dietary restriction and ad libitum antacid) treatment periods. We conclude that this regimen of cholestyramine was ineffective in symptomatic treatment of bile reflux gastritis.
D000328:Adult; D000368:Aged; D001646:Bile; D001647:Bile Acids and Salts; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005743:Gastrectomy; D005756:Gastritis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000209:etiology; D010146:Pain / Q000209:etiology; D011183:Postoperative Complications / Q000188:drug therapy*; D013651:Taste Disorders / Q000209:etiology; D014839:Vomiting / Q000209:etiology
D001647:Bile Acids and Salts; D002792:Cholestyramine Resin